Integrated Wealth Management (Palm Desert)’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Integrated Wealth Management (Palm Desert)’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10	Closed	–	–	1420
2015 Q4	$0	Hold	10	–	–	﹤0.01%	1466
2015 Q3	$0	Hold	10	–	–	﹤0.01%	1472
2015 Q2	$0	Buy	+10	New	+$598	﹤0.01%	1580

Other funds holding OREX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Integrated Wealth Management (Palm Desert)'s OREX Position: Q1 2016 in Review

Integrated Wealth Management (Palm Desert) sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2016, closing a stake of 10 shares.

Integrated Wealth Management (Palm Desert) first reported a position in OREX in Q2 2015 and held it in 3 quarters. The position peaked at $0 in Q4 2015. 104 funds tracked by Wall St. Rank hold OREX as of Q1 2016.

Integrated Wealth Management (Palm Desert) reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
Integrated Wealth Management (Palm Desert) sold 10 Orexigen Therapeutics, Inc. shares in Q1 2016.
Integrated Wealth Management (Palm Desert) first reported a position in Orexigen Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
Integrated Wealth Management (Palm Desert)'s Orexigen Therapeutics, Inc. position peaked at $0 in Q4 2015.
104 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2016.

Based on Integrated Wealth Management (Palm Desert)'s 13F filing for Q1 2016, filed 22 Apr 2016.